Point72 Hong Kong LTD G1 Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $43,866 - $92,401	-10,858 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $82,520 - $119,655	10,858 New	10,858 $83,000
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $64,648 - $102,889	-6,363 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $83,737 - $142,976	6,363 New	6,363 $85,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $43,422 - $80,497	-2,470 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $3,307 - $6,140	301 Added 13.88%	2,470 $44,000
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $25,051 - $51,513	2,169 New	2,169 $25,000
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $363 - $926	-38 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $344 - $1,000	38 New	38 $0
Q2 2019 Aug 14, 2019	SELL	$16.03 - $31.1 $769 - $1,492	-48 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $691 - $1,029	48 New	48 $1,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $4,853 - $15,091	-294 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $12,686 - $19,983	294 New	294 $15,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.